Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
Biotech Stocks: A Year in Review
Yahoo/TheStreet.com
Fri, 12/20/13 - 08:34 am
Amgen
Teva
Forest Labs
AstraZeneca
Medivation
JNJ
AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
Yahoo/Reuters
Thu, 12/19/13 - 08:12 am
Bristol-Myers Squibb
diabetes
AstraZeneca
AstraZeneca’s Arimidex Halves Breast Cancer Risk, Study Finds
Bloomberg
Tue, 12/17/13 - 08:57 am
Arimidex
AstraZeneca
breast cancer
[video]The Biggest Victims of the Patent Cliff in 2014
Motley Fool
Mon, 12/16/13 - 08:11 am
patents
AstraZeneca
Eli Lilly
Cymbalta
Nexium
Bristol, AstraZeneca withdraw diabetes drug in Germany, the day after it was endorsed by an FDA panel
Yahoo/Reuters
Fri, 12/13/13 - 10:43 am
Germany
diabetes
AstraZeneca
Dapagliflozin
Bristol-Myers Squibb
FDA panel throws dirt on Bristol-Myers' orphan drug metreleptin
Fierce Biotech
Thu, 12/12/13 - 04:15 pm
FDA
advisory panels
Bristol-Myers Squibb
metreleptin
AstraZeneca
partial lipodystrophy
Keep an Eye on AstraZeneca, Avanir, Bristol-Myers Squibb and VIVUS Today
Motley Fool
Thu, 12/12/13 - 11:12 am
AstraZeneca
Avair
Bristol-Myers Squibb
Vivus
metreleptin
Nuedexta
Avanafil
Sanofi
Stomach acid drugs may increase vitamin deficiency risk
Reuters
Wed, 12/11/13 - 12:11 pm
PPIs
H2RAs
Prevacid
Prilosec
Nexium
Tagamet
Zantac
GSK
Boehringer Ingelheim
P&G
AstraZeneca
Takeda
FDA staff cautious on AstraZeneca, Bristol diabetes drug
Yahoo/Reuters
Tue, 12/10/13 - 09:21 am
FDA
AstraZeneca
Bristol-Myers Squibb
Dapagliflozin
diabetes
AstraZeneca is first to win EU approval for an inhaled 4-in-1 flu vaccine
Fierce Pharma
Fri, 12/6/13 - 11:57 am
vaccines
Europe
Flu
flu vaccines
AstraZeneca
Fluenz Tetra
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Seeking Alpha
Thu, 12/5/13 - 06:43 pm
Pfizer
GSK
melanoma
Bristol-Myers Squibb
AstraZeneca
Daiichi Sankyo
Novartis
Yervoy
palbociclib
Mekinist
Zelboraf
AstraZeneca Eyes Forest Labs as Shares Rise
Motley Fool
Thu, 12/5/13 - 08:28 am
Forest Labs
AstraZeneca
M&A
5 Blockbuster Drugs Going Off Patent in 2014
Motley Fool
Wed, 12/4/13 - 08:38 am
patents
Eli Lilly
Evista
Teva
Copaxone
Novartis
Exforge
Sandostatin LAR
Nexium
AstraZeneca
Report: AstraZeneca kicks tires on Forest, eyes multibillion-dollar deal
Fierce Biotech
Tue, 12/3/13 - 07:27 pm
M&A
Forest Labs
AstraZeneca
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
AstraZeneca: A Positive Future Awaits This Company
Seeking Alpha
Tue, 11/26/13 - 04:48 pm
AstraZeneca
Bristol-Myers Squibb
Xigduo
diabetes
Dapagliflozin
3 Can't-Miss FDA Actions Coming in December
Motley Fool
Tue, 11/26/13 - 04:42 pm
FDA
Gilead Sciences
sofosbuvir
Forxiga
AstraZeneca
Bristol-Myers Squibb
GSK
Anoro Ellipta
Theravance
Opportunities in Lung Cancer Therapies
Motley Fool
Sun, 11/24/13 - 12:30 pm
lung cancer
non-small cell lung cancer
Avastin
Genentech
Roche
Tarceva
AstraZeneca
Iressa
Alimta
selumetinib
Array Biopharma
CO-1686
Clovis Oncology
AP26113
Ariad Pharmaceuticals
A Few Dozen Here, A Few Dozen There... More Pharma Layoffs
Pharmalot
Wed, 11/20/13 - 12:10 pm
layoffs
Actavis
AstraZeneca
Bayer
Keep an Eye on BioMarin, Amgen, Merck, and AstraZeneca Today
Motley Fool
Tue, 11/19/13 - 12:24 pm
Biomarin
Amgen
Merck
AstraZeneca
Pages
« first
‹ previous
…
101
102
103
104
105
106
107
108
109
…
next ›
last »